Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
79.79%
0%
79.79%
6 Months
84.53%
0%
84.53%
1 Year
56.25%
0%
56.25%
2 Years
140.83%
0%
140.83%
3 Years
267.13%
0%
267.13%
4 Years
370.85%
0%
370.85%
5 Years
286.03%
0%
286.03%
Lotus Health Group Co. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.81%
EBIT Growth (5y)
60.98%
EBIT to Interest (avg)
14.83
Debt to EBITDA (avg)
0.51
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.94
Tax Ratio
26.94%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
15.52%
ROE (avg)
10.21%
Valuation key factors
Factor
Value
P/E Ratio
40
Industry P/E
Price to Book Value
5.81
EV to EBIT
25.22
EV to EBITDA
20.05
EV to Capital Employed
7.80
EV to Sales
3.30
PEG Ratio
0.89
Dividend Yield
NA
ROCE (Latest)
30.93%
ROE (Latest)
14.42%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
1,016.50
961.80
5.69%
Operating Profit (PBDIT) excl Other Income
183.50
67.20
173.07%
Interest
7.50
6.60
13.64%
Exceptional Items
6.60
-1.00
760.00%
Consolidate Net Profit
146.20
64.40
127.02%
Operating Profit Margin (Excl OI)
180.50%
47.40%
13.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 5.69% vs 11.36% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 127.02% vs -30.53% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
3,439.40
2,637.10
30.42%
Operating Profit (PBDIT) excl Other Income
574.00
381.60
50.42%
Interest
37.60
33.40
12.57%
Exceptional Items
-63.00
-14.60
-331.51%
Consolidate Net Profit
320.10
199.50
60.45%
Operating Profit Margin (Excl OI)
139.70%
117.10%
2.26%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 30.42% vs 25.82% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 60.45% vs 52.64% in Dec 2024
About Lotus Health Group Co. 
Lotus Health Group Co.
FMCG
No Details Available.
Company Coordinates 
No Company Details Available






